| Name | Trityl Olmesartan Acid |
|---|---|
| Synonyms |
4-(2-Hydroxy-2-propanyl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylic acid
trityl olmesartan 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]- IMI060 OMST-B |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 901.0±75.0 °C at 760 mmHg |
| Molecular Formula | C43H40N6O3 |
| Molecular Weight | 688.816 |
| Flash Point | 498.7±37.1 °C |
| Exact Mass | 688.316162 |
| PSA | 118.95000 |
| LogP | 8.85 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.652 |
|
~99%
761404-85-7 |
| Literature: Krka Tovarna Zdravil, D.D., Novo Mesto; ZUPANCIC, Silvo Patent: EP2334668 B1, 2014 ; Location in patent: Paragraph 0077 ; |
|
~%
761404-85-7 |
| Literature: European Journal of Medicinal Chemistry, , vol. 46, # 9 p. 3564 - 3569 |
|
~%
761404-85-7 |
| Literature: European Journal of Medicinal Chemistry, , vol. 46, # 9 p. 3564 - 3569 |